Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2.

Hoseini, Sayed Shahabuddin; Dobrenkov, Konstantin; Pankov, Dmitry; Xu, Xiaoliang L; Cheung, Nai-Kong V

Hoseini, Sayed Shahabuddin; Dobrenkov, Konstantin; Pankov, Dmitry; Xu, Xiaoliang L; Cheung, Nai-Kong V.

Afiliação

Hoseini SS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Dobrenkov K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pankov D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Xu XL; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cheung NK; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Oncoimmunology ; 6(6): e1320625, 2017.

Article em En | MEDLINE | ID: mdl-28680755

Palavras-chave

Bispecific antibody; T cell exhaustion; chimeric antigen receptor; disialoganglioside; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google